Publicación:
Manejo de várices esofágicas en pacientes con cirrosis: tamización, profilaxis y tratamiento del sangrado agudo

dc.contributor.authorYepes Barreto, Ismaelspa
dc.contributor.authorMarín Zuluaga, Juan Ignaciospa
dc.date.accessioned2020-11-24 00:00:00
dc.date.available2020-11-24 00:00:00
dc.date.issued2020-11-24
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2015-2969
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13234
dc.identifier.urlhttps://doi.org/10.32997/rcb-2015-2969
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2969/2504
dc.relation.citationeditionNúm. 2 , Año 2015spa
dc.relation.citationendpage389
dc.relation.citationissue2spa
dc.relation.citationstartpage381
dc.relation.citationvolume6spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesde Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176.spa
dc.relation.referencesRipoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481-488.spa
dc.relation.referencesBhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-337.spa
dc.relation.referencesMerli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266-272.spa
dc.relation.referencesGroszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-2261.spa
dc.relation.referencesPrediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-989.spa
dc.relation.referencesD’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505.spa
dc.relation.referencesGarcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-938.spa
dc.relation.referencesNavasa M, Pares A, Bruguera M, Caballeria J, Bosch J, Rodes J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 1987;5:292- 298.spa
dc.relation.referencesEl-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000;95:3566-3573.spa
dc.relation.referencesKanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol 2010;8:709-717.spa
dc.relation.referencesde Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743-752.spa
dc.relation.referencesLi L, Yu C, Li Y. Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol 2011;25:147-155.spa
dc.relation.referencesTriantos CK, Burroughs AK. Prevention of the development of varices and first portal hypertensive bleeding episode. Best Pract Res Clin Gastroenterol 2007;21:31-42.spa
dc.relation.referencesHernandez-Gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, Minana J, et al. Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta- blockers. Am J Gastroenterol 2012;107:418-427.spa
dc.relation.referencesSenzolo M, Cholongitas E, Burra P, Leandro G, Thalheimer U, Patch D, Burroughs AK. beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int 2009;29:1189-1193.spa
dc.relation.referencesVlachogiannakos J, Goulis J, Patch D, Burroughs AK. Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis. Aliment Pharmacol Ther 2000;14:851-860.spa
dc.relation.referencesPrandi D, Rueff B, Roche-Sicot J, Sicot C, Maillard JN, Benhamou JP, Fauvert R. Lifethreatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt. Am J Surg 1976;131:204-209.spa
dc.relation.referencesCerqueira RM, Andrade L, Correia MR, Fernandes CD, Manso MC. Risk factors for inhospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol 2012;24:551-557.spa
dc.relation.referencesKrige JE, Kotze UK, Distiller G, Shaw JM, Bornman PC. Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg 2009;33:2127-2135.spa
dc.relation.referencesVillanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, Graupera I, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.spa
dc.relation.referencesBosch J, Thabut D, Bendtsen F, D’Amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004;127:1123-1130.spa
dc.relation.referencesBosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, D’Amico G, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 2008;47:1604-1614.spa
dc.relation.referencesMarti-Carvajal AJ, Karakitsiou DE, Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2012;3:CD004887.spa
dc.relation.referencesSeo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 2014;60:954-963.spa
dc.relation.referencesChavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, Uribe M. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther 2011;34:509-518.spa
dc.relation.referencesde la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suarez C. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005;41:572-578.spa
dc.relation.referencesLo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, Lin CK. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000;32:461-465.spa
dc.relation.referencesGonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Banares R, Albillos A. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008;149:109-122.spa
dc.relation.referencesPapatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 1999;30:612-622.spa
dc.relation.referencesHenderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006;130:1643-1651.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2969spa
dc.subjectVárices esofágicasspa
dc.subjectCirrosis hepáticaspa
dc.subjectHemorragia digestivaspa
dc.subjectTamizaje.spa
dc.titleManejo de várices esofágicas en pacientes con cirrosis: tamización, profilaxis y tratamiento del sangrado agudospa
dc.title.translatedManejo de várices esofágicas en pacientes con cirrosis: tamización, profilaxis y tratamiento del sangrado agudoeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: